Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

Product Pipeline


OraCAb is an orally administered immunotherapeutic product containing ovine polyclonal antibodies directed against recombinant fragments of Toxin A and Toxin B for the treatment of mild to moderate severity primary and recurrent Clostridium difficile infections (“CDI”).